Page last updated: 2024-10-23

azathioprine and Kwashiorkor

azathioprine has been researched along with Kwashiorkor in 1 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Kwashiorkor: A syndrome produced by severe protein deficiency, characterized by retarded growth, changes in skin and hair pigment, edema, and pathologic changes in the liver, including fatty infiltration, necrosis, and fibrosis. The word is a local name in Gold Coast, Africa, meaning displaced child. Although first reported from Africa, kwashiorkor is now known throughout the world, but mainly in the tropics and subtropics. It is considered to be related to marasmus. (From Dorland, 27th ed)

Research Excerpts

ExcerptRelevanceReference
"Kwashiorkor is one of the severe forms of protein-energy malnutrition."1.36Cutaneous presentation of kwashiorkor due to infantile Crohn's disease. ( Al Goufi, T; Al-Khenaizan, S; Al-Mubarak, L, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Al-Mubarak, L1
Al-Khenaizan, S1
Al Goufi, T1

Other Studies

1 other study available for azathioprine and Kwashiorkor

ArticleYear
Cutaneous presentation of kwashiorkor due to infantile Crohn's disease.
    European journal of pediatrics, 2010, Volume: 169, Issue:1

    Topics: Administration, Oral; Azathioprine; Crohn Disease; Diagnosis, Differential; Dose-Response Relationsh

2010